Blood Transfusion by Boston MedFlight Registry
Blood Transfusion by Boston MedFlight Registry
The primary aim of this observational registry is to study the outcomes of patients with
 hemorrhagic shock transported by Boston MedFlight receiving blood products during transport.
Boston MedFlight, a critical care transport organization, based on a consortium of the
 academic medical centers in Boston, will begin carrying PRBC in 2019. The program is intended
 to provide BMF clinicians with 24-hour immediate access to appropriate blood products to be
 utilized if needed for patients following life-threatening illness or injury. The four
 fundamental goals of this program are: save lives' ensure transfusion safety; minimize blood
 product waste; and conduct continuous quality assurance. Our goal is to observationally
 evaluate this new protocol of administering blood products in the pre-hospital setting. We
 will collect data on patients with hemorrhagic shock being transported by Boston MedFlight,
 who receive or would have been eligible to receive pre-hospital blood transfusion by the
 inclusion criteria.
Inclusion criteria:

 -  Adult patients who would be eligible to receive blood products;

 -  systolic blood pressure <90 mmHg

 -  a shock index of > 0.9

 -  clinical signs of shock as determined by the transport clinicians.

 Exclusion Criteria:

 -  Age < 18 years old